CatalystWireBeta

Annual General Meeting Results

In brief · summary, not quotable

No summary for this filing – the full text is below.

Full announcement

Select text to share a quote on X · sign in to keep highlights & notes in your EDX notes

Annual General Meeting

The Annual General Meeting of EDX Medical Group plc was held at Mezzanine Room, 1 Wimpole Street, Westminster, London, W1G 0AE on 30 September 2024 at 2:00 p.m.

All 11 resolutions put to members were passed on a poll. Resolutions 1 to 9 were passed as ordinary resolutions and resolutions 10 and 11 were passed as special resolutions.

ResolutionVotes for%Votes against%Votes withheld
Resolution 1 (Ordinary) To receive the Annual Report and Accounts of the Company for the financial year ended 31 March 2024 together with the Directors' reports and auditor's report on those accounts.189,456,532100.00000
Resolution 2 (Ordinary) To receive the Report of the Remuneration Committee for the financial year ended 31 March 2024.189,456,532100.00000
Resolution 3 (Ordinary) To re-elect Jason Holt as a director of the Company.189,456,532100.00000
Resolution 4 (Ordinary) To re-elect Dr Michael Hudson as a director of the Company.189,456,532100.00000
Resolution 5 (Ordinary) To re-elect Professor Sir Christopher Evans OBE as a director of the Company.189,456,532100.00000
Resolution 6 (Ordinary) To re-elect Professor Trevor Jones CBE as a director of the Company.189,456,532100.00000
Resolution 7 (Ordinary) To re-appoint PKF Littlejohn LLP as auditor of the Company.189,456,532100.00000
Resolution 8 (Ordinary) To authorise the Directors to determine the fees payable to the auditor.189,456,532100.00000
Resolution 9 (Ordinary) To authorise the directors to allot equity securities pursuant to section 551 of the Companies Act 2006, as set out in the Notice of Meeting.189,456,532100.00000
Resolution 10 (Special) To disapply statutory pre-emption rights generally, as set out in the Notice of Meeting.189,075,58499.84300,0000.1680,948
Resolution 11 (Special) To disapply statutory pre-emption rights pursuant to an acquisition or other capital investment, as set out in the Notice of Meeting.189,375,584100.000080,948

As at 30 September 2024, there were 347,357,576 ordinary shares in issue. Shareholders are entitled to one vote per share. Votes withheld are not votes in law and so have not been included in the calculation of the proportion of votes for and against a resolution.

Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note